New frontiers: cellular immunotherapy beyond cancerPublished: November 26, 2019
Matthew Brook, Joanna Hester & Fadi Issa
Cell-based immunotherapies have the potential to revolutionize our approach to patient care. The first steps towards routine administration of cell therapies are being taken with early clinical trials underway in transplantation and in patients living with autoimmune conditions such as Type 1 diabetes and inflammatory bowel disease. Here, we consider the need for cellular therapy in the clinical setting; the current position, with a specific focus on transplantation where significant steps forward are being taken, and what the next decade may hold in this rapidly developing field.DOI: 10.18609/cgti.2019.163
Citation: Cell & Gene Therapy Insights 2019; 5(12), 1229-1236.